{"id":5947,"date":"2026-10-02T14:01:12","date_gmt":"2026-10-02T14:01:12","guid":{"rendered":"https:\/\/www.diabetesasia.org\/journal\/?p=5947"},"modified":"2026-10-02T14:10:26","modified_gmt":"2026-10-02T14:10:26","slug":"screening-of-urinary-albumin-to-creatinine-ratio-a-real-world-audit-in-indian-outpatientdiabetes-care-settings","status":"publish","type":"post","link":"https:\/\/www.diabetesasia.org\/journal\/screening-of-urinary-albumin-to-creatinine-ratio-a-real-world-audit-in-indian-outpatientdiabetes-care-settings\/","title":{"rendered":"Screening of Urinary Albumin-to-Creatinine Ratio: A Real-World Audit in Indian OutpatientDiabetes-Care Settings"},"content":{"rendered":"\n

Screening of Urinary Albumin-to-Creatinine Ratio: A Real-World Audit in Indian Outpatient
Diabetes-Care Settings<\/p>\n\n\n\n

Dr. Prof. Ashok Sarin, MBBS, MD, FRCP (Edin)
Senior Consultant, Department of Nephrology, Indraprastha Apollo Hospital, Delhi NCR, India. Complete address: B\/25
SDA, New Delhi, India.
Corresponding author: Dr. Prof. Ashok Sarin, Senior Consultant, Indraprastha Apollo Hospital, Delhi NCR; B\/25 SDA,
New Delhi, India; drashoksarin@gmail.com<\/a><\/p>\n\n\n\n

Background: To describe the real-world distribution of urinary albumin-to-creatinine ratio (ACR) categories, reported from opportunistic screening of patients with diabetes mellitus (DM), attending outpatient diabetes-care settings across India.
Methods: This cross-sectional audit analyzed urinary ACR screening reports from a single spot test among 11,493 patients with DM across 14 Indian cities from 2024 to 2026.
Patients were classified into urinary ACR categories of <30 mg\/g, 30 to 300 mg\/g, or >300 mg\/g. The ACR <30 mg\/g category was further sub-classified into <10 mg\/g and 10 to 29 mg\/g subgroups. Data are summarized descriptively, as counts and percentages.
Results: Of the 11,493 patients screened with a single spot-test, 8,142 (70.8%) were reported with ACR <30 mg\/g, 2,182 (19.0%) with ACR 30 to 300 mg\/g, and 1,169 (10.2%) with ACR >300 mg\/g. Overall, 3,351 patients (29.2%) had urinary ACR at or above the 30 mg\/g threshold. Within the ACR <30 mg\/g category, 2,382 patients (20.7% of the total) had ACR <10 mg\/g while 5,760 (50.1% of the
total) fell within the high-normal 10 to 29 mg\/g range, making this the single largest subgroup in the cohort.
Conclusions: In this large real-world audit, roughly half of all patients with DM had urinary ACR values in the high-normal (10 to 29 mg\/g) range, and
29.2% had urinary ACR \u2265 30 mg\/g. Because low-grade albuminuria within the ‘normal’ range carries recognized prognostic
significance, these descriptive data have relevance for screening and monitoring of early urinary ACR in at-risk patients, in
primary and secondary care settings.
Keywords: albumin-to-creatinine ratio; albuminuria; high-normal albuminuria; diabetes mellitus; diabetic kidney disease; real-world audit; KDIGO; cardiovascular risk<\/p>\n\n\n\n